{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:52:33Z","timestamp":1784328753654,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002836","name":"Chang Gung University","doi-asserted-by":"publisher","award":["CMRPG8H0721"],"award-info":[{"award-number":["CMRPG8H0721"]}],"id":[{"id":"10.13039\/501100002836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biopha.2021.111886","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:44:02Z","timestamp":1628552642000},"page":"111886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Early treatment with combination of SS31 and entresto effectively preserved the heart function in doxorubicin-induced dilated cardiomyopathic rat"],"prefix":"10.1016","volume":"141","author":[{"given":"Jui-Ning","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Jye","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ruei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ching","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hon-Kan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2021.111886_bib1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ahj.2014.07.008","article-title":"Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population","volume":"168","author":"Cheng","year":"2014","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.biopha.2021.111886_bib2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.1149","article-title":"Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum","volume":"20","author":"Lund","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.biopha.2021.111886_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.biopha.2021.111886_bib4","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7\u20138","key":"10.1016\/j.biopha.2021.111886_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12471-012-0285-7","article-title":"Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies","volume":"20","author":"Hazebroek","year":"2012","journal-title":"Neth. Heart J."},{"issue":"6","key":"10.1016\/j.biopha.2021.111886_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4330\/wjc.v6.i6.478","article-title":"Cardiomyopathies: evolution of pathogenesis concepts and potential for new therapies","volume":"6","author":"Sisakian","year":"2014","journal-title":"World J. Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111886_bib7","first-page":"640","article-title":"Cardiomyopathy: an overview","volume":"96","author":"Brieler","year":"2017","journal-title":"Am. Fam. Physician"},{"issue":"3","key":"10.1016\/j.biopha.2021.111886_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jelectrocard.2018.02.014","article-title":"Cardiac resynchronization therapy with His bundle pacing as a method of treatment of chronic heart failure in patients with permanent atrial fibrillation and left bundle branch block","volume":"51","author":"Boczar","year":"2018","journal-title":"J. Electrocardiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111886_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.transproceed.2017.11.060","article-title":"Prognostic value of blood panel parameters in patients with dilated cardiomyopathy and advanced heart failure","volume":"50","author":"Sobrino-Marquez","year":"2018","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.biopha.2021.111886_bib10","first-page":"237","article-title":"The causes, consequences, and treatment of left or right heart failure","volume":"7","author":"Pazos-Lopez","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"issue":"2","key":"10.1016\/j.biopha.2021.111886_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","article-title":"Adriamycin. A new anticancer drug with significant clinical activity","volume":"80","author":"Blum","year":"1974","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.111886_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann. Intern. Med."},{"issue":"17","key":"10.1016\/j.biopha.2021.111886_bib13","first-page":"4766","article-title":"Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity","volume":"48","author":"Rajagopalan","year":"1988","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111886_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0163-7258(90)90088-J","article-title":"Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity","volume":"47","author":"Keizer","year":"1990","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.111886_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0022-2828(89)90782-7","article-title":"Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles","volume":"21","author":"Kim","year":"1989","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111886_bib16","first-page":"1789","article-title":"Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis","volume":"60","author":"Arola","year":"2000","journal-title":"Cancer Res."},{"issue":"51","key":"10.1016\/j.biopha.2021.111886_bib17","doi-asserted-by":"crossref","first-page":"40113","DOI":"10.1074\/jbc.M004108200","article-title":"Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells","volume":"275","author":"Wu","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.biopha.2021.111886_bib18","doi-asserted-by":"crossref","first-page":"22800","DOI":"10.1074\/jbc.272.36.22800","article-title":"A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes","volume":"272","author":"Jeyaseelan","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.111886_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.CIR.103.4.555","article-title":"Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase\/Akt phosphorylation and Bcl-xL\/caspase-3 interaction","volume":"103","author":"Negoro","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2021.111886_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2021.111886_bib21","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ndt\/gfu269","article-title":"Neprilysin inhibition in chronic kidney disease","volume":"30","author":"Judge","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"issue":"2","key":"10.1016\/j.biopha.2021.111886_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1523-1755.2001.060002715.x","article-title":"Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats","volume":"60","author":"Cao","year":"2001","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.biopha.2021.111886_bib23","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.V12102051","article-title":"Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone","volume":"12","author":"Taal","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111886_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"30","key":"10.1016\/j.biopha.2021.111886_bib25","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur. Heart J."},{"issue":"38","key":"10.1016\/j.biopha.2021.111886_bib26","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/eurheartj\/ehv330","article-title":"Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF","volume":"36","author":"Jhund","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.biopha.2021.111886_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14779072.2016.1128827","article-title":"Sacubitril\/valsartan (LCZ696) for the treatment of heart failure","volume":"14","author":"Gori","year":"2016","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2021.111886_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","article-title":"Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy","volume":"58","author":"Dai","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111886_bib29","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2012121216","article-title":"The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin","volume":"24","author":"Birk","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111886_bib30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/ars.2007.1892","article-title":"Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury","volume":"10","author":"Szeto","year":"2008","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.biopha.2021.111886_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/aps.2015.162","article-title":"Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice","volume":"37","author":"Lu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.biopha.2021.111886_bib32","first-page":"5220","article-title":"SS31 therapy effectively protects the heart against transverse aortic constriction-induced hypertrophic cardiomyopathy damage","volume":"9","author":"Lu","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.111886_bib33","first-page":"4612","article-title":"Early intramyocardial implantation of exogenous mitochondria effectively preserved left ventricular function in doxorubicin-induced dilated cardiomyopathy rat","volume":"12","author":"Yip","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2021.111886_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108954","article-title":"The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet","volume":"116","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.biopha.2021.111886_bib35","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.3390\/ijms19092782","article-title":"Combined therapy with SS31 and mitochondria mitigates myocardial ischemia-reperfusion injury in rats","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111886_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopha.2018.10.095","article-title":"Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat","volume":"109","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:10:14Z","timestamp":1776460214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221006685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":36,"alternative-id":["S0753332221006685"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111886","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early treatment with combination of SS31 and entresto effectively preserved the heart function in doxorubicin-induced dilated cardiomyopathic rat","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111886"}}